|
|
Other links at Articles > Medical Students |
| 2. |
Amgen Gets Conditional Approval for Vectibix in EU
|
|
|
Amgen Inc said on Wednesday the European Commission granted conditional marketing approval for its drug Vectibix (panitumumab) as a treatment for metastatic colon cancer. Reuters Health Information
|
|
|